Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

New therapies for alopecia areata show potential but need more research.

Improved delivery systems can enhance oleanolic acid's effectiveness in treating various conditions.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Changes in certain RNA and protein levels may contribute to alopecia areata and could be treatment targets.

Nod factor can trigger changes in legume root hairs with just one molecule.

Oregonin from Alnus japonica may help prevent hair loss and promote hair growth.

FOL-026 peptide may help hair growth and cardiovascular health by improving blood flow and cell functions.

Niosomal minoxidil was found to be more effective in increasing hair count and patient satisfaction than conventional minoxidil in treating hair loss.

The Annurca apple supplement significantly improved hair growth in people with hair loss.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Younger patients with severe alopecia areata often have nail problems.

Early recognition and treatment of atypical alopecia areata in infants are crucial.

Alopecia areata is now understood to be driven by genetic and immune factors.

A new microneedle patch effectively and safely treats alopecia areata.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Defective protein folding due to a mutation is key in ANE syndrome.

The botanical treatment for hair loss shows promise, especially for children.

Noni fruit extract, specifically the FEA-3 sub-fraction, can increase hair growth and reduce baldness in male rabbits, potentially acting like common hair loss treatments.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Alopecic and aseptic nodules of the scalp are rare, treatable, and often resolve with doxycycline or on their own.

Several doctors received research grants, new workshops and conferences were announced, and new officers were elected.

High-quality validation studies are needed to improve alopecia areata patient-reported outcome measures.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.